« Previous article
Free Hardy Diagnosti...

1st November 2021  Content supplied by: Hardy Diagnostics

Hardy Diagnostics Releases HardyCHROM™ Candida + auris


Hardy Diagnostics is pleased to announce its release of HardyCHROM™ Candida + auris, a chromogenic media recommended for the selective isolation and differential identification of Candida species. This medium allows for the identification of C. albicans, C. tropicalis, C. krusei, and the presumptive identification of C. glabrata. Colonies of C. auris will appear white with a characteristic teal to teal-green “bullseye” center.  Additionally, C. auris is also differentiated from other Candida species by a unique fluorogenic reaction under UV light. 

C. auris is an emerging pathogen that represents a serious multi-drug resistant (MDR) global threat. C. auris may persistently colonize the skin and hospital environment, making its transmission within and between healthcare settings more difficult to control.1 C. auris results in a wide range of mortality rates depending on the patient’s overall condition, underlying disease, geographic region, access to medical care, and age. 1

HardyCHROM™ Candida + auris can be used in conjunction with Rapid Trehalose Broth or GlabrataQuick to aid in the identification of C. glabrata.  

Find more information on HardyCHROM™ Candida + auris here or contact Hardy Diagnostics direct using the green "Request Information" button below.

Rossato, L. and A.L. Colombo. 2018. Candida auris: What Have We Learned About its Mechanisms of Pathogenicity? Frontiers in Micro. 


    

Tags:

Date Published: 1st November 2021

Source article link: View


View full company details